48 lines
2.6 KiB
Markdown
48 lines
2.6 KiB
Markdown
# [Topic]: [Subtitle — e.g. "Current State of X" / "What's Changed Since Y"]
|
|
|
|
*Compiled [Month Day, Year]*
|
|
|
|
Based on [primary source, e.g. "the XYZ Report" or "recent reporting from..."], this summarizes [what the doc covers — one sentence scope statement].
|
|
|
|
## The core idea
|
|
|
|
[2-4 sentences giving the central framing or thesis. If there's a named concept, coin, or official framing from a primary source, bold it, e.g. **"Term Name"**. State who said it / where it comes from.]
|
|
|
|
[Optional second paragraph: break the core idea into its main sub-components as a short list-in-prose, e.g. "In X, it does A. In Y, it does B. In Z, it does C."]
|
|
|
|
[Optional: one sentence tying this to a specific event/announcement that prompted the compilation — a conference, report release, deal, etc.]
|
|
|
|
## 1. [First major theme/angle]
|
|
|
|
[1 sentence framing what this section covers.]
|
|
|
|
- **[Entity/Company/Actor]** — [What they did, with concrete specifics: dollar amounts, dates, durations, capacities. One sentence, front-load the most important number/fact.]
|
|
- **[Entity/Company/Actor]** — [Same pattern.]
|
|
- **[Entity/Company/Actor]** — [Same pattern.]
|
|
|
|
[Optional closing sentence with an aggregate figure or industry-tracker stat, clearly flagged as coming from "one industry tracker" or similar if unaudited.]
|
|
|
|
**Counterpoint:** [1-2 sentences representing the strongest skeptical or critical take on this theme, attributed to a specific named source. Don't skip this if a credible counterpoint exists — it's what keeps the summary from reading as PR.]
|
|
|
|
## 2. [Second major theme/angle]
|
|
|
|
- **[Entity + specific initiative/product name]** — [What it does, who it's built with/partnered with, any concrete outcome metric.]
|
|
- **[Entity + specific initiative/product name]** — [Same pattern.]
|
|
- **[Entity + specific initiative/product name]** — [Same pattern.]
|
|
|
|
## 3. [Third major theme/angle — e.g. institutional/regulatory angle]
|
|
|
|
[Can be shorter — a paragraph instead of a bulleted list if there are fewer distinct items.]
|
|
|
|
## A caveat
|
|
|
|
[1-3 sentences of epistemic hygiene: note that the space is fast-moving, that figures are often industry-sourced rather than independently audited, and that claims should be read accordingly. This section is not optional — it's what separates a summary from stenography.]
|
|
|
|
---
|
|
|
|
## Sources
|
|
|
|
1. [Publisher/Org — "Exact title of piece"](URL) — [optional one-line note, e.g. "original statement" or "critical coverage"]
|
|
2. [Publisher/Org — "Exact title of piece"](URL)
|
|
3. [Publisher/Org — "Exact title of piece"](URL)
|
|
[... continue numbering every source actually used, in the order first cited or by rough importance] |